DrugPatentWatch Database Preview
Drugs in Development Information for Vonoprazan
What is the development status for investigational drug Vonoprazan?
Vonoprazan is an investigational drug.
There have been 13 clinical trials for Vonoprazan.
The most recent clinical trial was a Phase 3 trial, which was initiated on April 1st 2019.
The most common disease conditions in clinical trials are Esophagitis, Gastroesophageal Reflux, and Helicobacter Infections. The leading clinical trial sponsors are Takeda, Hamamatsu University, and St. Luke's Medical Center, Philippines.
There are sixteen US patents protecting this investigational drug and one hundred and fifty-one international patents.
Summary for Vonoprazan
| US Patents | 16 |
| International Patents | 151 |
| US Patent Applications | 27 |
| WIPO Patent Applications | 7 |
| Japanese Patent Applications | 1 |
| Clinical Trial Progress | Phase 3 (2019-04-01) |
| Vendors | 28 |
Recent Clinical Trials for Vonoprazan
| Title | Sponsor | Phase |
|---|---|---|
| Efficacy and Safety of Vonoprazan Compared to Lansoprazole in Participants With Erosive Esophagitis | Phathom Pharmaceuticals, Inc. | Phase 3 |
| Effectiveness of Vonoprazan vs Omeprazole as Empiric Therapy for Gastroesophageal Reflux Disease (GERD) Patients Without Alarm Features | St. Luke's Medical Center, Philippines | Phase 4 |
| A RCT of Triple Therapy With Proton Pump Inhibitor vs Vonoprazan for Helicobacter Pylori Gastritis | Changi General Hospital | Phase 4 |
Clinical Trial Summary for Vonoprazan
Top disease conditions for Vonoprazan
Top clinical trial sponsors for Vonoprazan
US Patents for Vonoprazan
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Vonoprazan | Start Trial | 5-aryl-1H-pyrrole-3-carbonitrile and a pharmaceutical product using the same | Takeda Pharmaceutical Company Limited (Osaka-Shi, JP) | Start Trial |
| Vonoprazan | Start Trial | Proton pump inhibitors | Takeda Pharmaceutical Company Limited (Osaka, JP) | Start Trial |
| Vonoprazan | Start Trial | Acid secretion inhibitor | Takeda Pharmaceutical Company Limited (Osaka, JP) | Start Trial |
| Vonoprazan | Start Trial | 1-heterocyclylsulfonyl, 2-aminomethyl, 5-(hetero-) aryl substituted 1-H-pyrrole derivatives as acid secretion inhibitors | Takeda Pharmaceutical Company Limited (Osaka, JP) | Start Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Vonoprazan
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Vonoprazan | China | 102421753 | 2029-02-25 | Start Trial |
| Vonoprazan | China | 104211618 | 2029-02-25 | Start Trial |
| Vonoprazan | China | 105524046 | 2029-02-25 | Start Trial |
| Vonoprazan | China | 108129374 | 2029-02-25 | Start Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
